Oklahoma HB 3834: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Status: Approved by Governor 05/12/2026 (as of 2026-05-12)

State: Oklahoma · Session: 2026 · Bill: HB 3834

Sponsors: Frix, May

View Oklahoma HB 3834 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.